Clinical Trials Browser

Phase 2 × Ototoxicity × Acetylcysteine × Clear all

NCT06297369 2024-03-07

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Phase 2 Unknown

Ototoxicity, Peripheral Nervous System Diseases